Insomnia related to biperiden withdrawal in two schizophrenic patients

International Clinical Psychopharmacology

Volumn 15, Issue 6, 2000, Pages 357-359

  Hirose, S ^a  

^a Fukui Prefectural University   (Japan)

Author keywords

Antipsychotics; Biperiden withdrawal; Cholinergic rebound; Insomnia; Schizophrenia

Indexed keywords

BIPERIDEN; FLUNITRAZEPAM; HALOPERIDOL; LORMETAZEPAM;

ADULT; ARTICLE; CASE REPORT; CHOLINERGIC ACTIVITY; CLINICAL EXAMINATION; DRUG WITHDRAWAL; FEMALE; HUMAN; INSOMNIA; PRIORITY JOURNAL; REBOUND; SCHIZOPHRENIA;

EID: 0033759895     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015060-00007     Document Type: Article

References (29)

1. A survey of tardive dyskinesia in psychiatric outpatients
2. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms
3. Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions
4. Withdrawal from neuroleptic drugs
5. Motor and mental aspects of extrapyramidal syndromes
6. Tardive dyskinesia and antiparkinsonian medication
7. Fluphenazine decanoate and tardive dyskinesia: A possible association
8. Tardive dyskinesia in schizophrenic outpatients: Prevalence and significant variables
9. Withdrawal syndromes associated with antipsychotic drugs
10. Treating extrapyramidal reactions: Some current issues
11. Differential effects of abrupt vs. gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients
12. Effect of anticholinergics on tardive dyskinesia. A controlled discontinuation study
13. Adverse effects of antiparkinson drug withdrawal
14. Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes
15. Cholinergic rebound in neuroleptic withdrawal syndromes
16. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs
17. Akathisia, pseudoakathisia and tardive dyskinesia: Clinical examples
18. Withdrawal of antiparkinson drugs
19. Tardive dyskinesia in psychiatric patients treated with neuroleptics
20. Akathisia: A side effect to be remembered
21. Recognizing and managing akathisia
22. Tardive dyskinesia and psychotropic drug history
23. Treatment of acute neuroleptic-induced movement disorders
24. The many faces of akathisia
25. Toward a more reliable diagnosis of akathisia
26. Behavioral toxicity of antipsychotic drugs
27. Clinical nonrecognition of neuroleptic-induced movement disorders: A cautionary study
28. Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement